These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 29548911)

  • 1. Involvement of GABAergic, BDNF and Nox-2 mechanisms in the prevention and reversal of ketamine-induced schizophrenia-like behavior by morin in mice.
    Ben-Azu B; Aderibigbe AO; Ajayi AM; Eneni AO; Umukoro S; Iwalewa EO
    Brain Res Bull; 2018 May; 139():292-306. PubMed ID: 29548911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Morin Attenuates Neurochemical Changes and Increased Oxidative/Nitrergic Stress in Brains of Mice Exposed to Ketamine: Prevention and Reversal of Schizophrenia-Like Symptoms.
    Ben-Azu B; Aderibigbe AO; Eneni AO; Ajayi AM; Umukoro S; Iwalewa EO
    Neurochem Res; 2018 Sep; 43(9):1745-1755. PubMed ID: 29956036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Doxycycline prevents and reverses schizophrenic-like behaviors induced by ketamine in mice via modulation of oxidative, nitrergic and cholinergic pathways.
    Ben-Azu B; Omogbiya IA; Aderibigbe AO; Umukoro S; Ajayi AM; Iwalewa EO
    Brain Res Bull; 2018 May; 139():114-124. PubMed ID: 29425796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Probable mechanisms involved in the antipsychotic-like activity of morin in mice.
    Ben-Azu B; Aderibigbe AO; Omogbiya IA; Ajayi AM; Owoeye O; Olonode ET; Iwalewa EO
    Biomed Pharmacother; 2018 Sep; 105():1079-1090. PubMed ID: 30021344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alpha-lipoic acid alone and combined with clozapine reverses schizophrenia-like symptoms induced by ketamine in mice: Participation of antioxidant, nitrergic and neurotrophic mechanisms.
    Vasconcelos GS; Ximenes NC; de Sousa CN; Oliveira Tde Q; Lima LL; de Lucena DF; Gama CS; Macêdo D; Vasconcelos SM
    Schizophr Res; 2015 Jul; 165(2-3):163-70. PubMed ID: 25937462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Morin decreases cortical pyramidal neuron degeneration via inhibition of neuroinflammation in mouse model of schizophrenia.
    Ben-Azu B; Aderibigbe AO; Ajayi AM; Eneni AO; Omogbiya IA; Owoeye O; Umukoro S; Iwalewa EO
    Int Immunopharmacol; 2019 May; 70():338-353. PubMed ID: 30852289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular mechanisms involved in the prevention and reversal of ketamine-induced schizophrenia-like behavior by rutin: the role of glutamic acid decarboxylase isoform-67, cholinergic, Nox-2-oxidative stress pathways in mice.
    Oshodi TO; Ben-Azu B; Ishola IO; Ajayi AM; Emokpae O; Umukoro S
    Mol Biol Rep; 2021 Mar; 48(3):2335-2350. PubMed ID: 33811574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversal and Preventive Pleiotropic Mechanisms Involved in the Antipsychotic-Like Effect of Taurine, an Essential β-Amino Acid in Ketamine-Induced Experimental Schizophrenia in Mice.
    Ben-Azu B; Uruaka CI; Ajayi AM; Jarikre TA; Nwangwa KE; Chilaka KC; Chijioke BS; Omonyeme MG; Ozege CB; Ofili EC; Warekoromor EB; Edigbue NL; Esiekpe UV; Akaenyi DE; Agu GO
    Neurochem Res; 2023 Mar; 48(3):816-829. PubMed ID: 36350433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Repeated psychosocial stress causes glutamic acid decarboxylase isoform-67, oxidative-Nox-2 changes and neuroinflammation in mice: Prevention by treatment with a neuroactive flavonoid, morin.
    Ben-Azu B; Emokpae O; Ajayi AM; Jarikre TA; Orhode V; Aderibigbe AO; Umukoro S; Iwalewa EO
    Brain Res; 2020 Oct; 1744():146917. PubMed ID: 32474018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Morin Pretreatment Attenuates Schizophrenia-Like Behaviors in Experimental Animal Models.
    Ben-Azu B; Aderibigbe AO; Omogbiya IA; Ajayi AM; Iwalewa EO
    Drug Res (Stuttg); 2018 Mar; 68(3):159-167. PubMed ID: 28962045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Haloperidol alters neurotrophic factors and epigenetic parameters in an animal model of schizophrenia induced by ketamine.
    Valvassori SS; da Rosa RT; Dal-Pont GC; Varela RB; Mastella GA; Daminelli T; Fries GR; Quevedo J; Zugno AI
    Int J Dev Neurosci; 2023 Dec; 83(8):691-702. PubMed ID: 37635268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sex difference alters the behavioral and cognitive performance in a rat model of schizophrenia induced by sub-chronic ketamine.
    Samizadeh MA; Abdollahi-Keyvani ST; Fallah H; Beigi B; Motamedi-Manesh A; Adibian S; Vaseghi S
    J Psychiatr Res; 2024 Oct; 178():180-187. PubMed ID: 39146821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Omega-3 prevents behavior response and brain oxidative damage in the ketamine model of schizophrenia.
    Zugno AI; Chipindo HL; Volpato AM; Budni J; Steckert AV; de Oliveira MB; Heylmann AS; da Rosa Silveira F; Mastella GA; Maravai SG; Wessler PG; Binatti AR; Panizzutti B; Schuck PF; Quevedo J; Gama CS
    Neuroscience; 2014 Feb; 259():223-31. PubMed ID: 24316471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of omega-3 dietary supplement in prevention of positive, negative and cognitive symptoms: a study in adolescent rats with ketamine-induced model of schizophrenia.
    Gama CS; Canever L; Panizzutti B; Gubert C; Stertz L; Massuda R; Pedrini M; de Lucena DF; Luca RD; Fraga DB; Heylmann AS; Deroza PF; Zugno AI
    Schizophr Res; 2012 Nov; 141(2-3):162-7. PubMed ID: 22954755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combinational effects of ketamine and amphetamine on behaviors and neurotransmitter systems of mice.
    Lai CC; Lee LJ; Yin HS
    Neurotoxicology; 2013 Jul; 37():136-43. PubMed ID: 23660488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention and reversal of ketamine-induced schizophrenia related behavior by minocycline in mice: Possible involvement of antioxidant and nitrergic pathways.
    Monte AS; de Souza GC; McIntyre RS; Soczynska JK; dos Santos JV; Cordeiro RC; Ribeiro BM; de Lucena DF; Vasconcelos SM; de Sousa FC; Carvalho AF; Macêdo DS
    J Psychopharmacol; 2013 Nov; 27(11):1032-43. PubMed ID: 24045882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ketamine administration induces early and persistent neurochemical imbalance and altered NADPH oxidase in mice.
    Schiavone S; Morgese MG; Bove M; Colia AL; Maffione AB; Tucci P; Trabace L; Cuomo V
    Prog Neuropsychopharmacol Biol Psychiatry; 2020 Jan; 96():109750. PubMed ID: 31446158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroprotective effects of the ethanol stem bark extracts of Terminalia ivorensis in ketamine-induced schizophrenia-like behaviors and oxidative damage in mice.
    Ben-Azu B; Aderibigbe AO; Ajayi AM; Iwalewa EO
    Pharm Biol; 2016 Dec; 54(12):2871-2879. PubMed ID: 27250524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversal of schizophrenia-like symptoms and immune alterations in mice by immunomodulatory drugs.
    da Silva Araújo T; Maia Chaves Filho AJ; Monte AS; Isabelle de Góis Queiroz A; Cordeiro RC; de Jesus Souza Machado M; de Freitas Lima R; Freitas de Lucena D; Maes M; Macêdo D
    J Psychiatr Res; 2017 Jan; 84():49-58. PubMed ID: 27697587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Binge and Subchronic Exposure to Ketamine Promote Memory Impairments and Damages in the Hippocampus and Peripheral Tissues in Rats: Gallic Acid Protective Effects.
    Brum GF; Rosa HZ; Rossato DR; Rosa JLO; Metz VG; Milanesi LH; Burger ME
    Neurotox Res; 2020 Aug; 38(2):274-286. PubMed ID: 32458406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.